Ligand validation:7WL0

OGA: N-OXALYLGLYCINE

OGA is a Ligand Of Interest in 7WL0 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7WL0_OGA_C_302	62%	28%	0.171	0.965	1.38	1.53	2	4	1	0	100%	1
7WL0_OGA_E_302	61%	26%	0.165	0.956	1.38	1.62	2	3	0	0	100%	1
7WL0_OGA_A_302	56%	27%	0.175	0.948	1.35	1.58	2	3	1	0	100%	1
7WL0_OGA_G_302	46%	27%	0.189	0.925	1.5	1.44	1	1	2	0	100%	1
7WL0_OGA_I_302	42%	29%	0.198	0.92	1.25	1.56	1	2	0	0	100%	1
4NRP_OGA_A_302	72%	13%	0.132	0.956	2.29	1.69	1	3	0	0	100%	1
4GJY_OGA_A_502	100%	25%	0.024	0.993	2.38	0.72	2	-	0	0	100%	1
3MS5_OGA_A_390	99%	26%	0.048	0.984	1.22	1.76	1	3	0	0	100%	1
5A1F_OGA_A_1756	99%	17%	0.054	0.985	2.18	1.44	2	2	0	0	100%	1
6F4T_OGA_A_502	98%	14%	0.053	0.979	2.26	1.62	4	2	0	0	100%	1
6F4R_OGA_A_502	98%	20%	0.062	0.984	1.98	1.4	1	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.